Medanta Global Health Limited (NSE: Medanta, BSE: 543654) continues to consolidate its position as a leading private healthcare provider in North and East India, with the inauguration of a 550-bed super-specialty hospital in Noida. Operational since September 2025, the facility currently offers 226 beds, 81 ICU beds, and five operating theatres, supported by over 150 doctors and advanced medical technologies, signaling significant capacity expansion in the Delhi/NCR region.
For Q2 FY2026, Medanta reported a consolidated total income of INR 11,189 million, reflecting 14.8% year-on-year and 6.4% quarter-on-quarter growth. EBITDA excluding Noida rose 13.7% to INR 2,804 million, while net profit increased 21.1% to INR 1,584 million, highlighting efficient operations across mature and developing hospitals. International patient revenue surged 48.5% to INR 762 million, and OPD pharmacy revenue grew 23.9% to INR 456 million, underscoring robust demand and pricing power.
The quarter also included capacity expansions in Patna and Lucknow, and the proposed 500–750 bed Mumbai hospital, indicating Medanta’s continued network-wide growth and strong economic outlook in India’s private healthcare sector.
